HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Y L Wu Selected Research

snail family transcription factors

1/2013Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Y L Wu Research Topics

Disease

5Neoplasms (Cancer)
03/2014 - 08/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015 - 03/2014
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2011 - 01/2008
1Disease Progression
05/2014
1Lung Neoplasms (Lung Cancer)
03/2014
1Glomerulonephritis
10/2010
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
10/2010
1Purpura
10/2010
1Osteoarthritis
07/2010
1Anoxia (Hypoxia)
02/2008
1Disease Susceptibility (Diathesis)
01/2008
1Astrocytoma (Pilocytic Astrocytoma)
12/2001
1Stomach Neoplasms (Stomach Cancer)
12/2001
1Hepatocellular Carcinoma (Hepatoma)
12/2001
1Eosinophilia
11/2001
1Asthma (Bronchial Asthma)
11/2001
1Inflammation
11/2001
1Paralysis (Palsy)
09/2001
1Cholecystitis
12/2000
1Gallstones (Gallstone)
12/2000
1Necrosis
12/2000
1Adenocarcinoma
08/2000
1Embryonal Carcinoma
08/2000
1Granulosa Cell Tumor
08/2000
1Neoplasm Metastasis (Metastasis)
08/2000

Drug/Important Bio-Agent (IBA)

3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 08/2000
3Messenger RNA (mRNA)IBA
03/2014 - 08/2000
3Complement C4 (Complement Component 4)IBA
10/2010 - 01/2008
2bevacizumabFDA Link
05/2014 - 03/2014
2Protein Kinases (Protein Kinase)IBA
03/2014 - 01/2013
2DNA (Deoxyribonucleic Acid)IBA
02/2008 - 11/2001
1erlotinib (CP 358,774)FDA Link
09/2015
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
09/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2015
1thymidine 5'-triphosphate (TTP)IBA
05/2014
1Carboplatin (JM8)FDA LinkGeneric
05/2014
1Paclitaxel (Taxol)FDA LinkGeneric
05/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2014
1Y 27632IBA
01/2013
1Acetylcysteine (Siran)FDA LinkGeneric
01/2013
1snail family transcription factorsIBA
01/2013
1Complement C1r (Complement Component 1r)IBA
10/2011
1Complement C4bIBA
10/2010
1Immunoglobulin G (IgG)IBA
10/2010
1Antigen-Antibody Complex (Immune Complex)IBA
10/2010
1Epinephrine (Adrenaline)FDA LinkGeneric
07/2010
1Betamethasone (Celestone)FDA Link
07/2010
1Morphine (MS Contin)FDA LinkGeneric
07/2010
1ropivacaine (Naropin)FDA LinkGeneric
07/2010
1TramadolFDA LinkGeneric
07/2010
1celecoxib (Celebrex)FDA Link
07/2010
1LuciferasesIBA
02/2008
1Glucose (Dextrose)FDA LinkGeneric
02/2008
1Small Interfering RNA (siRNA)IBA
02/2008
1Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA
02/2008
1CCAAT-Enhancer-Binding Protein-alphaIBA
02/2008
1Hypoxia-Inducible Factor 1IBA
02/2008
1Proteins (Proteins, Gene)IBA
12/2001
1H-cadherin (T-cadherin)IBA
12/2001
1Sulindac (Copal)FDA LinkGeneric
12/2001
1Interleukin-12 (IL 12)IBA
11/2001
1Dermatophagoides pteronyssinus antigen p 1IBA
11/2001
1CytokinesIBA
11/2001
1Foix Chavany Marie syndromeIBA
09/2001
1Superoxides (Superoxide)IBA
12/2000
1Lipid PeroxidesIBA
12/2000
1CatalaseIBA
12/2000
1Phospholipases (Phospholipase)IBA
12/2000
1Glutathione PeroxidaseIBA
12/2000
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
12/2000
1beta Carotene (Betacarotene)FDA Link
12/2000
1Vitamin EFDA LinkGeneric
12/2000
1Annexin A1IBA
12/2000
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
09/2015 - 03/2014
1Traction
01/2013
1Analgesia
07/2010
1Intra-Articular Injections
07/2010
1Arthroplasty
07/2010
1Immunotherapy
11/2001